Search Results
Slidesets
Trough dabrafenib plasma concentrations can predict occurrence of adverse effects requiring dose reduction in metastatic melanoma
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
What challenges remain in viral hepatitis- Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
O_4: Evaluation of the Drug-Drug Interaction Potential between Cobicistat-Boosted Protease Inhibitors and Statins - Dr Joseph Custodio
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
The clinical significance of low level viremia during treatment with cART- Martin Markowitz, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
How to combine new treatments? Clinical approach | Marion Peters, MD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Roadblocks to implementation | Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2016
Slidesets
HIV Transmission in the US and fitness effects of drug-resistant viruses - Joel Wertheim, PhD
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Long-acting Cabotegravir Pharmacokinetics With and Without Oral Lead-in for HIV PrEP - Kelong Han
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Acute HCV and Reinfection | Loreta Kondili
Presented at:
European Meeting on HIV & Hepatitis 2024